Arylalkenyl and aryalkynyl substituted imidazoquinoline compounds, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
本发明涉及含有芳基
烯丙基和芳基炔基的
咪唑喹啉化合物、含有该化合物的制药组合物、
中间体以及将这些化合物作为免疫调节剂的方法,用于在动物体内诱导细胞因子合成并治疗包括病毒性和肿瘤性疾病在内的疾病。